Innovation Pharmaceuticals Inc (IPIX)

[BioTechMaven]

The inevitable is coming: an upwards movement in anticipation of topline IBD, interim/topline Psoriais, OM breakthrough/topline, and Kevetrin interim/topline in 2H17. The Fud team senses that the positive interpretation (good vs evil) may actuality be a reality and will have an increasingly difficult fight ahead as we move toward the reveals. Partnerships by way of excellent data and no trials failed with three lead drugs in mid stage trials is the threat. Remain convinced that we have a 10-100x return from where we sit today for the longs. Good luck. Data is an indisputable force once it emerges.